Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. NLM AIDSLINE Important note: Information in this article was accurate in 1982. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Hepatitis B in homosexual men: prevalence of infection and factors related to transmission.

J Infect Dis. 1982 Jul;146(1):7-15. Unique Identifier : AIDSLINE MED/82215402
Schreeder MT; Thompson SE; Hadler SC; Berquist KR; Zaidi A; Maynard JE; Ostrow D; Judson FN; Braff EH; Nylund T; Moore JN Jr; Gardner P; Doto IL; Reynolds G

Abstract: Of 3,816 homosexual men examined in five sexually transmitted disease clinics in the United States, 6.1% had hepatitis B surface antigen, 52.4% had antibody to hepatitis B surface antigen, and 3.0% of the men who had no other indicator of infection with hepatitis B virus (HBV) had antibody to hepatitis B core antigen. The rate of seropositivity for HBV indicated by the presence of one or more of these serologic markers was 61.5%; seropositivity was significantly related to the duration of regular homosexual activity and to the number of nonsteady male sexual contacts in the four months before the patients were interviewed. Anal-genital intercourse, oral-anal intercourse, and rectal douching were significantly related to evidence of HBV infection, but oral-oral contact and oral-genital contact were not. Trauma to the rectal mucosa is a feature common to the practices that were significantly related to seropositivity for HBV.
Keywords: Adolescence Adult Hepatitis B/*EPIDEMIOLOGY/IMMUNOLOGY/TRANSMISSION Hepatitis B Surface Antigens/ANALYSIS *Homosexuality Human Irrigation/ADVERSE EFFECTS Male Mucous Membrane Rectum/INJURIES Risk Sex Behavior United States JOURNAL ARTICLE

KWDadolescenceadulthepatitisb/KWDepidemiology/immunology/transmissionhepatitisbsurfaceantigens/analysisKWDhomosexualityhumanirrigation/adverseeffectsmalemucousmembranerectum/injuriesrisksexbehaviorunitedstatesjournalarticle
821030
M82A0022

Copyright © 1982 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1982. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1982. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .